A molecular mystery that could potentially lead to new cancer treatments is solved thanks to a team at Harvard and the Broad Institute of MIT. The researchers discovered how a strange molecule, known as ML210, works to kill drug-resistant cancer cells by inducing a cellular process called ferroptosis. They believe...


















